Journal details
ONCOIMMUNOLOGY
TAYLOR & FRANCIS INC · ISSN 2162-402X · eISSN 2162-402X
SCIEScopusMEDLINEPubMedDOAJ
Overview
ONCOIMMUNOLOGY. ISSN 2162-402X · eISSN 2162-402X. published by TAYLOR & FRANCIS INC. United States. Oncology · Immunology. impact factor 6.2 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 49 articles · 2025: 121 articles · 2024: 120 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of ONCOIMMUNOLOGY?
The impact factor recorded for ONCOIMMUNOLOGY is 6.2 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of ONCOIMMUNOLOGY?
ONCOIMMUNOLOGY is listed in CAS Zone 2.
Which databases index ONCOIMMUNOLOGY?
ONCOIMMUNOLOGY is indexed in SCIE, Scopus, MEDLINE, PubMed, DOAJ. Confirm on the journal website and the database itself before submitting.